1-3 of 3
Christine Dube
Close
Sort by
Journal Articles

Busulfan Dosing May Affect Survival Following Reduced Intensity Stem Cell Transplantation in Patients with Acute Myelogeneous Leukemia.

Karen K Ballen, MD, Steven L McAfee, MD, Bimalangshu R Dey, MD, Christine Dube, BA, Eyal C Attar, MD, Yi-Bin Chen, MD, Philip C Amrein, MD, Thomas R Spitzer, MD
Journal: Blood
Blood (2009) 114 (22): 4328.
https://doi.org/10.1182/blood.V114.22.4328.4328
Published: 2009
Journal Articles

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Stephen S. Chung, MD, Thomas R. Spitzer, MD, David T. Ting, MD, Christine Dube, Andrew J. Yee, MD, Karen Ballen, MD, Steven L. McAfee, MD, Eyal Attar, MD, Bimalangshu R. Dey, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5128.
https://doi.org/10.1182/blood.V110.11.5128.5128
Published: 2007
Journal Articles

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Bimalangshu R. Dey, MD, PhD, Andrew J. Yee, MD, Steven McAfee, MD, Christine Dube, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, Susan Saidman, PhD, Karen Malikowski, Frederic Preffer, PhD, Megan Sykes, MD, Thomas R. Spitzer, MD
Journal: Blood
Blood (2007) 110 (11): 5088.
https://doi.org/10.1182/blood.V110.11.5088.5088
Published: 2007